Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS

OBJECTIVE: To determine the safety of intrathecal autologous adipose-derived mesenchymal stromal cell treatment for amyotrophic lateral sclerosis (ALS). METHODS: Participants with ALS were enrolled and treated in this phase I dose-escalation safety trial, ranging from 1 × 10(7) (single dose) to 1 ×...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurology
Autori principali: Staff, Nathan P., Madigan, Nicolas N., Morris, Jonathan, Jentoft, Mark, Sorenson, Eric J., Butler, Greg, Gastineau, Dennis, Dietz, Allan, Windebank, Anthony J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5123559/
https://ncbi.nlm.nih.gov/pubmed/27784774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003359
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi